The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 54, Issue , 2014, Pages 243-248

  Wróbel, Andrzej ^a   Serefko, Anna ^a   Wlaź, Piotr ^b   Poleszak, Ewa ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Antidepressant like activity; Dexamethasone; Forced swim test; Mice

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DEXAMETHASONE; GLUCOCORTICOID; IMIPRAMINE; MIANSERIN; MOCLOBEMIDE; TIANEPTINE; ANTIDEPRESSANT AGENT; THIAZEPINE DERIVATIVE;

ACUTE DRUG ADMINISTRATION; ADULT; ANALYSIS OF VARIANCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG THERAPY; FORCED SWIM TEST; IMMOBILITY; LOCOMOTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; REPEATED DRUG DOSE; SINGLE DRUG DOSE; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; SWIMMING;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSION; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; IMIPRAMINE; MALE; MIANSERIN; MICE; MOCLOBEMIDE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; SWIMMING; THIAZEPINES;

EID: 84904044563     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.06.008     Document Type: Article

References (59)

1. Ago Y., Arikawa S., Yata M., Yano K., Abe M., Takuma K., et al. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacology 2008, 55:1355-1363.
2. Akarsu E.S., Palaolu Ö., Ayhan I.H. Behavioral effects of acute and chronic Moclobemide administrations in mice. Eur Neuropsychopharmacol 1996, 6:S1-S12.
3. Belanoff J.K., Rothschild A.J., Cassidy F., DeBattista C., Baulieu E.E., Schold C., et al. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 2002, 52:386-392.
4. Bourin M., Colombel M.C., Redrobe J.P., Nizard J., Hascoet M., Baker G.B. Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Prog Neuropsychopharmacol Biol Psychiatry 1998, 22:343-351.
5. Brotto L.A., Gorzalka B.B., Barr A.M. Paradoxical effects of chronic corticosterone on forced swim behaviours in aged male and female rats. Eur J Pharmacol 2001, 424:203-209.
6. Brown E.S., Suppes T. Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 1998, 5:239-246.
7. Crowley J.J., Blendy J.A., Lucki I. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berlin) 2005, 183:257-264.
8. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
9. Danilczuk Z., Ossowska G., Wrobel A., Lupina T. Glucocorticoids modulate behavioral effects induced by dopaminergic agonists in rats. Pol J Pharmacol 2001, 53:467-473.
10. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
11. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
12. Dinan T. Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis. Hum Psychopharmacol 2001, 16:89-93.
13. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 2003, 985:420-444.
14. Feldmann R.E., Maurer M.H., Hunzinger C., Lewicka S., Buergers H.F., Kalenka A., et al. Reduction in rat phosphatidylethanolamine binding protein-1 (PEBP1) after chronic corticosterone treatment may be paralleled by cognitive impairment: a first study. Stress 2008, 11:134-147.
15. Gorzalka B.B., Hanson L.A. Sexual behavior and wet dog shakes in the male rat: regulation by corticosterone. Behav Brain Res 1998, 97:143-151.
16. Gorzalka B., Hanson L., Harrington J., Killam S., Campbell-Meiklejohn D. Conditioned taste aversion: modulation by 5-HT receptor activity and corticosterone. Eur J Pharmacol 2003, 471:129-134.
17. Gourley S.L., Kiraly D.D., Howell J.L., Olausson P., Taylor J.R. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol Psychiatry 2008, 64:884-890.
18. Gregus A., Wintink A.J., Davis A.C., Kalynchuk L.E. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 2005, 156:105-114.
19. Haynes L.E., Griffiths M.R., Hyde R.E., Barber D.J., Mitchell I.J. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience 2001, 104:57-69.
20. Haynes L.E., Barber D., Mitchell I.J. Chronic antidepressant medication attenuates dexamethasone-induced neuronal death and sublethal neuronal damage in the hippocampus and striatum. Brain Res 2004, 1026:157-167.
21. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997, 20:78-84.
22. Idayu N.F., Hidayat M.T., Moklas M.A., Sharida F., Raudzah A.R., Shamima A.R., et al. Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine 2011, 18:402-407.
23. Johnson S.A., Fournier N.M., Kalynchuk L.E. Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res 2006, 168:280-288.
24. Kalynchuk L.E., Gregus A., Boudreau D., Perrot-Sinal T.S. Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behav Neurosci 2004, 118:1365-1377.
25. Kamphuis P.J., Gardoni F., Kamal A., Croiset G., Bakker J.M., Cattabeni F., et al. Long-lasting effects of neonatal dexamethasone treatment on spatial learning and hippocampal synaptic plasticity: involvement of the NMDA receptor complex. FASEB J 2003, 17:911-913.
26. Katagiri H., Kagaya A., Nakae S., Morinobu S., Yamawaki S. Modulation of serotonin2A receptor function in rats after repeated treatment with dexamethasone and L-type calcium channel antagonist nimodipine. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:1269-1281.
27. Kelly W.F., Checkley S.A., Bender D.A., Mashiter K. Cushing's syndrome and depression - a prospective study of 26 patients. Br J Psychiatry 1983, 142:16-19.
28. Laakmann G., Hennig J., Baghai T., Schule C. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients. Ann N Y Acad Sci 2004, 1032:279-282.
29. Lacerda A.L., Keshavan M.S., Hardan A.Y., Yorbik O., Brambilla P., Sassi R.B., et al. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry 2004, 55:353-358.
30. Li S.X., Fujita Y., Zhang J.C., Ren Q., Ishima T., Wu J., et al. Role of the NMDA receptor in cognitive deficits, anxiety and depressive-like behavior in juvenile and adult mice after neonatal dexamethasone exposure. Neurobiol Dis 2014, 62:124-134.
31. Lussier A.L., Romay-Tallon R., Kalynchuk L.E., Caruncho H.J. Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice. Neuropharmacology 2011, 60:1064-1074.
32. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 2003, 100:1387-1392.
33. Marks W., Fournier N.M., Kalynchuk L.E. Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength. Physiol Behav 2009, 98:67-72.
34. Meyer T.S., Smith S.T., Middlemas D.S. Chronic corticosterone treatment does not elicit depression-like behavior in adolescent rats. FASEB J 2012, 26:509.
35. Murphy B.E., Filipini D., Ghadirian A.M. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci 1993, 18:209-213.
36. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 2008, 583:115-127.
37. Okuyama-Tamura M., Mikuni M., Kojima I. Modulation of the human glucocorticoid receptor function by antidepressive compounds. Neurosci Lett 2003, 342:206-210.
38. Pariante C.M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A.H., et al. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol 2001, 134:1335-1343.
39. Pariante C.M., Hye A., Williamson R., Makoff A., Lovestone S., Kerwin R.W. The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 2003, 28:1553-1561.
40. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003, 43:60-66.
41. Patel S.S., Udayabanu M. Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice. Metab Brain Dis 2014, 29:121-130.
42. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
43. Qiu F., Zhong X., Mao Q., Huang Z. The antidepressant-like effects of paeoniflorin in mouse models. Exp Ther Med 2013, 5:1113-1116.
44. Ribeiro S.C., Tandon R., Grunhaus L., Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 1993, 150:1618-1629.
45. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
46. Sigwalt A.R., Budde H., Helmich I., Glaser V., Ghisoni K., Lanza S., et al. Molecular aspects involved in swimming exercise training reducing anhedonia in a rat model of depression. Neuroscience 2011, 192:661-674.
47. Stanbury R.M., Graham E.M. Systemic corticosteroid therapy - side effects and their management. Br J Ophthalmol 1998, 82:704-708.
48. Starkman M.N., Schteingart D.E., Schork M.A. Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome. Psychiatry Res 1986, 19:177-188.
49. Sterner E.Y., Kalynchuk L.E. Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:777-790.
50. Sugimoto Y., Yamada S., Yamada J. The 5-HT2 receptor antagonist reduces immobility of mice treated with the atypical antidepressant mianserin in the forced swimming test. Biol Pharm Bull 2002, 25:1479-1481.
51. Vyas A., Bernal S., Chattarji S. Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Res 2003, 965:290-294.
52. Wang J., Barak L.S., Mook R.A., Chen W. Glucocorticoid hedgehog agonists in neurogenesis. Vitam Horm 2011, 87:207-215.
53. Watanabe Y., Gould E., McEwen B.S. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res 1992, 588:341-345.
54. Wellman C.L. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 2001, 49:245-253.
55. Wlaź P., Kasperek R., Wlaź A., Szumiło M., Wróbel A., Nowak G., et al. NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice. Pharmacol Rep 2011, 63:1526-1532.
56. Wróbel A., Nowak G., Ossowska G., Danilczuk Z., Zebrowska-Łupina I., Wielosz M. Effect of chronic treatment with dexamethasone on brain dopamine receptors in mice. Pol J Pharmacol 2004, 56:399-405.
57. Wróbel A., Zebrowska-Łupina I., Wielosz M. Dexamethasone reduces locomotor stimulation induced by dopamine agonists in mice. Pharmacol Rep 2005, 57:451-457.
58. Young A.H., Gallagher P., Watson S., Del-Estal D., Owen B.M., Ferrier I.N. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 2004, 29:1538-1545.
59. Zhao Y., Ma R., Shen J., Su H., Xing D., Du L. A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 2008, 581:113-120.